A Study of the Safety and Efficacy of Synvisc and Depo-Medrol in Patients With Osteoarthritis of the Hip
Clinical trial NCT00131326 · COMPLETED
Trial details
- NCT number
- NCT00131326
- Sponsor
- Genzyme, a Sanofi Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2003-11-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.